Friday, October 23, 2026

USD/EUR Bearish Momentum: 0.83% Down In The Last 5 Sessions

ViaNews Editorial Team

August 16, 2024

USD/EUR Bearish Momentum: 0.83% Down In The Last 5 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.83% for the last 5 sessions. At 13:07 EST on Friday, 16 August, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 1.203% up from its 52-week low and 5.068% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.16%, a negative 0.06%, and a positive 0.24%, respectively.

USD/EUR's highest amplitude of average volatility was 0.34% (last week), 0.24% (last month), and 0.24% (last quarter), respectively.

News about

  • Usd/jpy edges higher in a familiar range, retakes 147.00 mark amid risk-on mood. According to FXStreet on Wednesday, 14 August, "Heading into the key data risk, the upbeat market mood is seen undermining the safe-haven Japanese Yen (JPY) and acting as a tailwind for the USD/JPY pair.", "The USD/JPY pair attracts some dip-buying during the Asia session on Wednesday and climbs back above the 147.00 mark in the last hour, reversing the previous day's modest downfall. "
  • Usd/jpy consolidates in a familiar rage, holds comfortably above 147.00 mark. According to FXStreet on Thursday, 15 August, "Apart from this, a generally positive risk tone undermines demand for the safe-haven JPY and continues to offer some support to the USD/JPY pair. ", "The USD/JPY pair struggles to capitalize on the previous day's goodish rebound from the 146.00 round figure, or the weekly low and oscillates in a narrow trading band during the Asian session on Thursday. "
  • According to FXStreet on Thursday, 15 August, "In terms of support levels, the USD/JPY pair may navigate the region arounda seven-month low of 141.69, reached on August 5. ", "On the upside, the USD/JPY pair may encounter immediate resistance at the nine-day Exponential Moving Average (EMA) around the 147.53 level, followed by the 50-day EMA at 153.40 level, with the potential to test the resistance level at 154.50, where previous support has now turned into resistance."
  • According to FXStreet on Friday, 16 August, "The USD/JPY pair edges lower as the US Dollar loses ground amid lower Treasury yields. ", "In terms of support levels, the USD/JPY pair may encounter immediate support at the nine-day EMA, around 148.09. "
  • Usd/jpy price analysis: establishes sequence of higher highs and higher lows. According to FXStreet on Friday, 16 August, "However, in the case of USD/JPY the pair failed to decline and instead traded sideways before breaking decisively higher on August 15."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com